Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the study record and its version history remain unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T23:11:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.9%
    Check dated 2026-10-24T23:16:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T23:32:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T23:26:39.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, was added to the study record history and the prior revision, v3.6.6, was removed, reflecting an updated version of the record in the history trail.
    Difference
    0.1%
    Check dated 2026-09-19T22:21:02.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the record history, replacing the previous 'Revision: v3.6.5'. This reflects a minor update to the page's underlying software version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T22:00:35.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.